Short Interest in BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Decreases By 80.0%

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) saw a large drop in short interest during the month of March. As of March 31st, there was short interest totalling 300 shares, a drop of 80.0% from the March 15th total of 1,500 shares. Based on an average daily trading volume, of 56,400 shares, the days-to-cover ratio is presently 0.0 days.

BriaCell Therapeutics Price Performance

BCTXW opened at $0.08 on Tuesday. BriaCell Therapeutics has a fifty-two week low of $0.03 and a fifty-two week high of $1.30. The stock has a fifty day moving average of $0.10 and a 200-day moving average of $0.23.

About BriaCell Therapeutics

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.